Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1,800,000 Profiles
- More than 3,500 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Hermann Mucke
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Concepts & Ideas
Organizations
Occupations
Procedures
Sign-in to see full Profile
Network (preview)
7
Rainer, Michael
6
Haushofer, Manfred
3
Krüger-Rainer, Christine
2
Kraxberger, E
2
Jellinger, Kurt
2
Masching, Andreas
1
Tragl, Karl-Heinz
1
Weissgram, Silvia
1
Zehetmayer, Sonja
1
Jungwirth, Susanne
1
Kasper, Siegfried
1
Krampla, Wolfgang
1
Fischer, Peter
1
Kurz, Alexander
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Hermann Mucke (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Mucke Hermann A M
Small-molecule endothelin receptor antagonists: a review of patenting activity across therapeutic areas.
IDrugs : the investigational drugs journal 2009;12(6):366-75.
-
2008: Mucke Hermann A M
Pulmonary arterial hypertension: on the way to a manageable disease.
Current opinion in investigational drugs (London, England : 2000) 2008;9(9):957-62.
-
2007: Mucke Hermann A M
Cardiovascular developments: patent highlights July to December 2006.
Current opinion in investigational drugs (London, England : 2000) 2007;8(3):193-200.
-
2007: Mucke Hermann A M
New ocular therapeutics: a view from the patenting perspective.
IDrugs : the investigational drugs journal 2007;10(1):37-41.
-
2006: Mucke Hermann A M
Cardiovascular and renal developments: patent highlights January to June 2006.
Current opinion in investigational drugs (London, England : 2000) 2006;7(9):792-8.
-
2006: Rainer Michael K; Mucke H A M; Zehetmayer S; Krampla W; Kuselbauer T; Weissgram S; Jungwirth S; Tragl K H; Fischer P
Data from the VITA Study do not support the concept of vascular depression.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2006;14(6):531-7.
-
2006: Mucke Hermann A M
Genomics-based cardiovascular drug development: the challenges are just beginning.
Current opinion in investigational drugs (London, England : 2000) 2006;7(3):203-5.
-
2006: Mucke Hermann A M
Neurology--18th world congress. 5-11 November 2005, Sydney, Australia.
IDrugs : the investigational drugs journal 2006;9(1):19-22.
-
2005: Mucke Hermann A M
Tumor progression & therapeutic resistance--Second International Conference.
IDrugs : the investigational drugs journal 2005;8(11):894-7.
-
2005: Mucke Hermann A M
The European Association of Addiction Therapy - Inaugural Conference.
IDrugs : the investigational drugs journal 2005;8(10):816-7.
-
2005: Mucke Hermann A M
The failing heart as a drug target: are we finally seeing progress?
Current opinion in investigational drugs (London, England : 2000) 2005;6(9):870-3.
-
2005: Rainer Michael K; Mucke Hermann A M; Masching Andreas J; Haushofer Manfred; Karger Martin; Kasper Siegfried; Kurz Alexander
[State of the art management of BPSD in dementia]
Psychiatrische Praxis 2005;32(1):31-8.
-
2004: Rainer Michael K; Krüger-Rainer Christine; Haushofer Manfred; Mucke Hermann Am
Zotepine for behavioural and psychological symptoms in dementia: an open-label study.
CNS drugs 2004;18(15):1165.
-
2004: Rainer Michael K; Mucke Hermann A M; Krüger-Rainer Christine; Haushofer Manfred; Kasper Sigfried
Zotepine for behavioural and psychological symptoms in dementia: an open-label study.
CNS drugs 2004;18(1):49-55.
-
2003: Mucke Hermann A
Renal therapeutics: patent highlights January to June 2003.
Current opinion in investigational drugs (London, England : 2000) 2003;4(9):1048-52.
-
2003: Mucke Hermann A M
Rotigotine Schwarz Pharma.
IDrugs : the investigational drugs journal 2003;6(9):894-9.
-
2003: Mucke Hermann A M
CEP-1347 (Cephalon).
IDrugs : the investigational drugs journal 2003;6(4):377-83.
-
2002: Mucke Hermann
Sixth COngress of the European Federation of Neurological Societies.
IDrugs : the investigational drugs journal 2002;5(12):1125-7.
-
2002: Mucke Hermann
Therapies in development for the treatment of migraine.
Expert opinion on investigational drugs 2002;11(12):1813-20.
-
2002: Mucke Hermann A M
Frovatriptan Vernalis.
Current opinion in investigational drugs (London, England : 2000) 2002;3(9):1373-80.
-
2002: Mucke Hermann A M
Localization and function of 5-HT2 receptors.
IDrugs : the investigational drugs journal 2002;5(8):776-8.
-
2001: Mucke H A
Ageing and dementia: current and future concepts.
IDrugs : the investigational drugs journal 2001;4(11):1240-3.
-
2001: Mucke H
TAK-147 (Takeda).
Current opinion in investigational drugs (London, England : 2000) 2001;2(11):1595-9.
-
2001: Rainer M; Mucke H A; Krüger-Rainer C; Kraxberger E; Haushofer M; Jellinger K A
Cognitive relapse after discontinuation of drug therapy in Alzheimer's disease: cholinesterase inhibitors versus nootropics.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(11):1327-33.
-
2000: Mucke H A
Recent trends in ADHD pharmacotherapy: do we need more divided attention?
IDrugs : the investigational drugs journal 2000;3(9):979-82.
-
2000: Rainer M; Kraxberger E; Haushofer M; Mucke H A; Jellinger K A
No evidence for cognitive improvement from oral nicotinamide adenine dinucleotide (NADH) in dementia.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(12):1475-81.
-
1999: Rainer M; Mucke H A; Masching A; Haushofer M
[Non-cognitive symptom profiles in dementia--experience from psychiatric services and memory clinics]
Psychiatrische Praxis 1999;26(2):71-5.
Sign-in to see more
